Last Updated on October 17, 2024 by The Health Master
The United States Food and Drug Administration (USFDA) has given approval to Lupin for its Abbreviated New Drug Application (ANDA), Prasugrel tablets USP, 5 mg and 10 mg, a generic equivalent of Effient tablets, 5 mg and 10 mg of Cosette Pharma.
The product will be manufactured at Lupin’s facility in Goa, a statement from Lupin informed today.
Prasugrel tablets USP, 5 mg and 10 mg, had estimated annual sales of $18 million in the US (IQVIA MAT September 2022), the statement further said.
USFDA approves Fesoterodine Fumarate Extended-Release tablets
USFDA gives final approval for this Insomnia drug
USFDA approves this monoclonal antibody to treat multiple sclerosis
USFDA gives final approval to this breast cancer injection
USFDA gives approval for Fulvestrant injection
USFDA gives approval for this Genetic Disorder dru
IPC publishes draft monograph revision proposals
High demand for Indian generic drugs in China
NPPA may fix retail price of drugs under phase IV Clinical trials
Govt Job: For the post of Director at CDTL, CDSCO
List of approved FDCs (Fixed Dose Combinations) Updated
List of approved New Drugs Updated
NPPA extends ceiling price of LMO, Oxygen Inhalation
Drug licences of these two firms suspended: FDA Manipur
Fake pharma firm busted, two arrested
Latest Notifications regarding Pharmaceutical
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
